Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 Pneumonia Who Developed Bradycardia
| Autor: | Dana M. Harris, Jose Valery, Launia J. White, Mohamed Omer, Claudia R. Libertin, Fernando F. Stancampiano, Michael G. Heckman |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Bradycardia
Adult Male Sinus bradycardia Antibodies Monoclonal Humanized bradycardia Electrocardiography Young Adult Heart rate medicine pneumonia Humans Sinus rhythm Medicine & Medical Specialties cardiovascular diseases Aged Retrospective Studies Aged 80 and over medicine.diagnostic_test business.industry COVID-19 Retrospective cohort study General Medicine Middle Aged medicine.disease lenzilumab Hospitalization Pneumonia Anesthesia Cohort cardiovascular system Female medicine.symptom business circulatory and respiratory physiology |
| Zdroj: | Southern Medical Journal |
| ISSN: | 1541-8243 0038-4348 |
| Popis: | Multiple systemic abnormalities have been described in patients with coronavirus disease 2019, including various degrees of cardiovascular involvement ranging from mild myocarditis to severe pulmonary hypertension, ventricular dysfunction, and arrhythmias. This article describes the clinical characteristics and outcomes of patients with coronavirus disease 2019 pneumonia who developed bradycardia. Supplemental digital content is available in the text. Objective To assess the clinical characteristics and clinical outcomes of bradycardic patients with coronavirus disease 2019 (COVID-19) pneumonia. Methods The electronic medical records of 221 consecutive patients hospitalized for COVID-19 pneumonia between June and September 2020 were retrospectively reviewed. Patient characteristics, electrocardiographic data, and clinical and laboratory information were retrospectively collected. Patients not treated with drugs that blunt chronotropic response (nodal) were analyzed separately. Results Only patients whose heart rate was |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|